Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism
- 25 May 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (7), e2449-e2456
- https://doi.org/10.1210/clinem/dgaa282
Abstract
Context The Endocrine Society Guidelines for the diagnosis of primary aldosteronism (PA) suggest that confirmatory tests (CFT) are not required when the following criteria are met: plasma aldosterone concentration (PAC) is >20ng/dl, plasma renin is below detection levels and hypokalemia is present. The evidence for the applicability of the guideline criteria is limited. Objective To develop and validate optimized criteria for sparing CFT in the diagnosis of PA. Design and setting The optimized criteria were developed in a Chinese cohort using the captopril challenge test, verified by saline infusion test (SIT) and fludrocortisone suppression test (FST) and validated in an Australian cohort. Participants Hypertensive patients who completed PA screening and CFT. Main outcome measure Diagnostic value of the optimized criteria. Results In the development cohort (518 PA and 266 non-PA), hypokalemia, PAC and plasma renin concentration (PRC) were selected as diagnostic indicators by multivariate logistic analyses. The combination of PAC>20ng/dl plus PRC<2.5 μIU/ml plus hypokalemia had much higher sensitivity than the guideline criteria (0.36 vs 0.11). The optimized criteria remained superior when the SIT or FST were used as CFT. Non-PA patients were not misdiagnosed by either criteria, but the percentage of patients in whom CFT could be spared was higher with the optimized criteria. In the validation cohort (125 PA and 81 non-PA), the sensitivity of the optimized criteria was also significantly higher (0.12 vs. 0.02). Conclusions Hypertensive patients with PAC>20ng/dl, PRC<2.5μIU/ml plus hypokalemia can be confidently diagnosed with PA without confirmatory tests.Funding Information
- National Natural Science Foundation of China (81670785, 81800701, 81870567, 81800731, 81970720)
- Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission (2018QNXM001)
- Chongqing Outstanding Youth Funds (cstc2019jcyjjq0006)
This publication has 34 references indexed in Scilit:
- Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertensionJournal of Hypertension, 2014
- An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary AldosteronismHypertension, 2014
- Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronismInternational Journal of Nephrology and Renovascular Disease, 2011
- A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive reninJournal of Hypertension, 2010
- A screening procedure for primary aldosteronism based on the Diasorin Liaison® automated chemiluminescent immunoassay for direct reninAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2010
- Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate MeasurementClinical Chemistry, 2009
- The Simultaneous Measurement of Plasma-Aldosterone- and -Renin-Concentration Allows Rapid Classification of all Disorders of the Renin-Aldosterone SystemExperimental and Clinical Endocrinology & Diabetes, 2007
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJournal of the American College of Cardiology, 2006
- Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence ImmunoassaysClinical Chemistry, 2004
- Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five ContinentsJournal of Clinical Endocrinology & Metabolism, 2004